Literature DB >> 8782923

Surgical management of complete atrioventricular canal associated with tetralogy of Fallot.

A Bertolini1, P Dalmonte, G L Bava, G Calza, F Lerzo, L Zannini, G Pongiglione, R Moretti.   

Abstract

Between 1984 and 1993, 12 children with an atrioventricular canal and tetralogy of Fallot underwent surgical repair. The mean(s.d.) age at operation was 58(18) months, and the mean(s.d.) body weight 15(4) kg. Nine patients underwent 11 palliative procedures. The ventricular septal defect was closed through a combined (right atrial and right ventricular) approach in nine cases, and through a right atrial approach in three, using a prosthetic patch with a wide anterior extension, secured with a running suture. The 'ostium primum' defect was closed with a separate prosthetic patch in 11 cases (double-patch technique). Right ventricular outflow obstruction was relieved by a composite infundibular patch (seven cases) or a transanular patch (five). There were four hospital deaths (33%). These were caused by low cardiac output in three cases and infection in one (three deaths occurred in patients with a transanular patch). One patient has so far died during follow-up. Assessment at 50(36) months by echo-Doppler showed moderate-to-severe 'mitral' regurgitation in three cases, and moderate 'tricuspid' regurgitation with right ventricular dysfunction in one case. Two patients have required further surgery.

Entities:  

Mesh:

Year:  1996        PMID: 8782923     DOI: 10.1016/0967-2109(95)00122-0

Source DB:  PubMed          Journal:  Cardiovasc Surg        ISSN: 0967-2109


  2 in total

1.  A single misstep in cardiac development explains the co-occurrence of tetralogy of fallot and complete atrioventricular septal defect in Down syndrome.

Authors:  Hoang H Nguyen; Patrick Y Jay
Journal:  J Pediatr       Date:  2014-04-08       Impact factor: 4.406

2.  Tetralogy of Fallot with atrioventricular septal defect: surgical strategies for repair and midterm outcome of pulmonary valve-sparing approach.

Authors:  Umang Gupta; Anastasios C Polimenakos; Chawki El-Zein; Michel N Ilbawi
Journal:  Pediatr Cardiol       Date:  2012-10-27       Impact factor: 1.655

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.